Discover the reasons behind recurring nosebleeds beyond dry air, including medication effects, clotting disorders, structural ...

Therini Bio reveals promising Phase 1a trial results for THN391, a potential breakthrough treatment for neurodegenerative ...

"Therini Bio reports data from trial of THN391 for neurodegenerative conditions" was originally created and published by ...

Anticoagulant drugs, whether classical ones such as warfarin and heparin or newer ones such as dabigatran and apixaban, can be effective for treating and preventing deep vein thrombosis, myocardial ...

Therini Bio intends to commence two Phase 1b trials imminently, evaluating THN391 for the treatment of patients with Alzheimer’s Disease and Diabetic Macular Edema.

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

Hympavzi is now approved in the U.K. for the prevention of bleeds in adults and adolescents with hemophilia A or B, without ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Recruitment stopped early due to positive exploratory and efficacy outcomes ...

Purpose: The retinal pigment epithelium (RPE) transmits growth signals from the neural retina to the choroid in the emmetropization pathway, but the underlying molecular mechanisms remain poorly ...

Research Center for Marine Drugs, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127 People’s Republic of China ...